Delivery Order SPE2DB22D3016-SPE2DB23FBRA3
Award Date 9/5/23
Potential Completion Date 9/6/23
Potential Value $8.6K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a $57,282.72 firm fixed price delivery order contract to supply 4561431450 units of ABRAXANE 100 MG VIALS. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by July 10, 2023 under the terms of this order issued against an existing DLA contract vehicle. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $12,013.11 to Amerisourcebergen Drug Corporation for 4561772065 units of the cancer drug Abraxane in 100mg vials. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a facility in Conshohocken, Pennsylvania by August 11, 2023 under the terms of the order. The Defense Logistics Agency is the Department of Defense's combat logistics support agency, indicating this contract supports...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $24,640.84 to Amerisourcebergen Drug Corporation for 4561772767 units of ABRAXANE 100 MG VIALS. As the prime contractor, Amerisourcebergen will deliver the chemotherapy drug to its place of performance in Conshohocken, Pennsylvania by August 11, 2023 to support the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were identified. The delivery order was issued against an...
- The Defense Logistics Agency awarded a delivery order valued at $8,741.22 to AmerisourceBergen Drug Corp for the supply of Abraxane 100 mg vials, with performance completion scheduled for September 17, 2025. This competitively awarded, firm fixed price contract carries no set-aside designation and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $25,931.08 to Amerisourcebergen Drug Corporation for 4561919850 units of ABRAXANE 100 MG VIALS. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the requested pharmaceutical products to a location in Conshohocken, Pennsylvania by August 24, 2023 under the terms of the contract. The Defense Logistics Agency is the Department of Defense's combat logistics support agency, responsible for...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 24, 2025, for the supply of Abraxane 100 mg vials, a chemotherapy medication used in cancer treatment. This firm fixed-price delivery order, valued at $8,436.70 with an ultimate completion date of June 25, 2025, was competitively awarded without set-aside provisions. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency (DLA) Troop Support Medical. The $3,045.01 order is to supply 100 mg vials of ABRAXANE, an anticancer medication, for delivery to a DLA facility in Conshohocken, Pennsylvania by December 13, 2023. No set-aside designation was applied to this procurement. As a prime vendor, Amerisourcebergen routinely provides pharmaceuticals and medical...
- The Defense Logistics Agency awarded a $78,033 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg vials of ABRAXANE, an injectable chemotherapy drug. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place in Conshohocken, Pennsylvania over a one day period from August 16-17, 2023. No subcontractors or set aside designations were...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $28,620.65 by the Defense Logistics Agency's Medical Supply Chain for the procurement of Abraxane 100 mg vials. The contract, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, is structured as a firm fixed-price delivery order without a set-aside designation. Performance will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a $17,782 delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Abraxane, a chemotherapy medication used in cancer treatment. This firm fixed price contract, awarded November 10, 2025, with completion by November 12, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The award required no set-aside designation and was competitively awarded through open...